Nephropathy Global Clinical Trials Review, H2, 2015

1
Nephropathy Global Clinical Trials Review, H2,
2015
(Type, Mode of action, Crop Type and Geography) -
Size, Share, Global Trends, Company Profiles,
Demand, Insights, Analysis, Research, Report,
Opportunities, Segmentation and Forecast, 2013 -
2020
TELEPHONE [phone]E-MAIL
sales_at_researchbeam.com
Published on Oct 2014
2


Report Overview

• Nephropathy Global Clinical Trials Review, H2,
  2015 provides an overview of Nephropathy clinical
  trials scenario. This report provides top line
  data relating to the clinical trials on
  Nephropathy. Report includes an overview of trial
  numbers and their average enrollment in top
  countries conducted across the globe. The report
  offers coverage of disease clinical trials by
  region, country (G7 E7) , phase, trial status,
  end points status and sponsor type. Report also
  provides prominent drugs for in-progress trials
  (based on number of ongoing trials) .
• Summary
• Nephropathy Global Clinical Trials Review, H2,
  2015 provides an overview of Nephropathy clinical
  trials scenario. This report provides top line
  data relating to the clinical trials on
  Nephropathy. Report includes an overview of trial
  numbers and their average enrollment in top
  countries conducted across the globe. The report
  offers coverage of disease clinical trials by
  region, country (G7 E7) , phase, trial status,
  end points status and sponsor type. Report also
  provides prominent drugs for in-progress trials
  (based on number of ongoing trials) . Global Data
  Clinical Trial Reports are generated using Global
  Datas proprietary database Pharma eTrack Clinical
  trials database. Clinical trials are collated
  from 80 different clinical trial registries,
  conferences, journals, news etc across the globe.
  Clinical trials database undergoes periodic
  update by dynamic process.
• Read More At http//www.researchbeam.com/nephro
  pathy-global-clinical-trials-review-h2-2015-market
  

3


Table of Content
Table of Contents 2List of Tables 4List of
Figures 5Introduction 6Nephropathy 6Report
Guidance 6Clinical Trials by Region 7Clinical
Trials and Average Enrollment by Country 8Top
Five Countries Contributing to Clinical Trials in
Asia-Pacific 10Top Five Countries Contributing
to Clinical Trials in Europe 11Top Countries
Contributing to Clinical Trials in North America
12Top Countries Contributing to Clinical Trials
in Middle East and Africa 13Top Five Countries
Contributing to Clinical Trials in Central and
South America 14Clinical Trials by G7 Countries
Proportion of Nephropathy to Genito Urinary
System And Sex Hormones Clinical Trials
15Clinical Trials by Phase in G7 Countries
16Clinical Trials in G7 Countries by Trial
Status 17Clinical Trials by E7 Countries
Proportion of Nephropathy to Genito Urinary
System And Sex Hormones Clinical Trials
18Clinical Trials by Phase in E7 Countries
19Clinical Trials in E7 Countries by Trial
Status 20Clinical Trials by Phase 21
4


Table of Content
In Progress Trials by Phase 22Clinical Trials
by Trial Status 23Clinical Trials by End Point
Status 24Unaccomplished Trials of Nephropathy
25Subjects Recruited Over a Period of Time
29Clinical Trials by Sponsor Type 30Prominent
Sponsors 31Top Companies Participating in
Nephropathy Therapeutics Clinical Trials
32Prominent Drugs 33Clinical Trial Profiles
34Clinical Trial Overview of Top Companies
34Novartis AG 34Clinical Trial Overview of
Novartis AG 34F. Hoffmann-La Roche Ltd.
35Clinical Trial Overview of F. Hoffmann-La
Roche Ltd. 35Pfizer Inc. 36Clinical Trial
Overview of Pfizer Inc. 36Mallinckrodt Plc
37 Enquire At http//www.researchbeam.com/nephr
opathy-global-clinical-trials-review-h2-2015-marke
t/enquire-about-report
5



FOR MORE DETAILS
Visit us at
http//www.researchbeam.com/nephropathy-global-cli
nical-trials-review-h2-2015-market
Stay With Us
5933 NE Win Sivers Drive,205, Portland, OR
97220United States
TELEPHONE [phone] DIRECT 1 (503)
894-6022E-MAIL sales_at_researchbeam.com